EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

ED50 and ED95 of Remimazolam Combined with Sufentanil for Sedation During Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Prospective Dose-Finding Study

Anna Wei, Lianchun Ou, Yujie Chen, Meihua Chen, Fangyun Wei, Xiaofei Mo iD

Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-13

DOI: 10.2147/dddt.s526223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Anna Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, Guangxi, 545000, People's Republic of China. Hauptthemen laut MEDLINE: Sufentanil, Leiomyoma, Benzodiazepines, Hypnotics and Sedatives. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SufentanilLeiomyomaBenzodiazepinesHypnotics and SedativesHigh-Intensity Focused Ultrasound AblationUterine NeoplasmsHumansFemaleProspective StudiesDose-Response Relationship, DrugAdultMiddle Aged

Stichwörter der Autor:innen

benzodiazepinesremimazolamsurgical sedationultrasound-guided high-intensity focused ultrasounduterine fibroids

Substanzen

SufentanilremimazolamBenzodiazepinesHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Anesthesiology, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, Guangxi, 545000, People's Republic of China.
  • Department of Anesthesiology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, Guangdong, 510623, People's Republic…

ORCID-Profile: Xiaofei Mo

Zitieren

APA

Wei, A., Ou, L., Chen, Y., Chen, M., Wei, F., & Mo, X. (2026). ED50 and ED95 of Remimazolam Combined with Sufentanil for Sedation During Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Prospective Dose-Finding Study. Drug Design, Development and Therapy, Volume 20, 1-13. https://doi.org/10.2147/dddt.s526223

Vancouver

Wei A, Ou L, Chen Y, Chen M, Wei F, Mo X. ED50 and ED95 of Remimazolam Combined with Sufentanil for Sedation During Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Prospective Dose-Finding Study. Drug Design, Development and Therapy. 2026;Volume 20:1-13. doi:10.2147/dddt.s526223

BibTeX
@article{Wei2026,
  author = {Wei, Anna and Ou, Lianchun and Chen, Yujie and Chen, Meihua and Wei, Fangyun and Mo, Xiaofei},
  title = {ED50 and ED95 of Remimazolam Combined with Sufentanil for Sedation During Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Prospective Dose-Finding Study},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--13},
  doi = {10.2147/dddt.s526223}
}
Kostenlos starten →